NASDAQ NMS - GLOBAL MARKET · INVA
+2.08% · +$0.4200 · Vol 1.4M
Market closed · last close 4:00 PM ET · price as of 16:01:11 ET
Innoviva Inc

Innoviva Inc

Pharmaceuticals
$20.66
Card
Relationship Map

Follow $INVA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $INVA by email

Veridion Score

BETAMEDIUM CONF · 5 of 6 factors measuredMethodology
Sentiment absence reason unknown
INVA
Innoviva Inc
Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Upper range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

73/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is INVA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading INVA catalysts
About Innoviva Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2004
Employees
159
Country
US

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$20.28
Day high
$20.79
Day low
$20.28
Previous close
$20.24
52W high
$24.24
-14.77% from high
52W low
$16.67
53% of range
Market cap
$1.5B
P/E
7.05×
EPS
$2.93
Beta
-0.46
Shares out
72.2M
Volume
1.4M
1.60× rel vol
Avg volume
857.1K
VWAP
$20.61
Price history computed in-house
1W
-2.27%
1M
-2.73%
3M
-12.35%
1Y
+11.25%
YTD
+3.35%
SMA 50 $21.09 · below
SMA 200 $21.76 · below
52W position 53%

INVA overview

Veridion Score
73
Registered · 2026-09-24
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around INVA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading INVA Form 4 filings
Public disclosures

Congress activity in INVA

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for INVA in the cached public ledger.

Federal contracts

INVA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for INVA in this window.
Lobbying spend

INVA lobbying filings, year to date.

Registered lobbying filings matched to Innoviva Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for INVA in this window.
Loading news for INVA
Analyst ratings
Sovereign unlock shows live analyst consensus for INVA.
Options
Sovereign unlock shows live options positioning for INVA.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.